| TLR4-based immunotherapeutics in cancer: a review of the achievements and shortcomings MA Shetab Boushehri, A Lamprecht Molecular pharmaceutics 15 (11), 4777-4800, 2018 | 133 | 2018 |
| Drug delivery strategies for the treatment of malignant gliomas D Allhenn, MAS Boushehri, A Lamprecht International journal of pharmaceutics 436 (1-2), 299-310, 2012 | 116 | 2012 |
| MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers MS Singh, SN Tammam, MAS Boushehri, A Lamprecht Pharmacological research 126, 2-30, 2017 | 64 | 2017 |
| Preparation, characterization and optimization of glipizide controlled release nanoparticles J Emami, MSS Boushehri, J Varshosaz Research in pharmaceutical sciences 9 (5), 301-314, 2014 | 49 | 2014 |
| Nanotechnology as a platform for the development of injectable parenteral formulations: a comprehensive review of the know-hows and state of the art MA Shetab Boushehri, D Dietrich, A Lamprecht Pharmaceutics 12 (6), 510, 2020 | 42 | 2020 |
| Drug delivery to the inflamed intestinal mucosa–targeting technologies and human cell culture models for better therapies of IBD O Hartwig, MAS Boushehri, KS Shalaby, B Loretz, A Lamprecht, CM Lehr Advanced Drug Delivery Reviews 175, 113828, 2021 | 40 | 2021 |
| A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides MA Shetab Boushehri, MMA Abdel-Mottaleb, A Béduneau, Y Pellequer, ... Drug Delivery 25 (1), 1414-1425, 2018 | 28 | 2018 |
| Collagenase loaded chitosan nanoparticles for digestion of the collagenous scar in liver fibrosis: The effect of chitosan intrinsic collagen binding on the success of targeting S El-Safy, SN Tammam, M Abdel-Halim, ME Ali, J Youshia, ... European Journal of Pharmaceutics and Biopharmaceutics 148, 54-66, 2020 | 27 | 2020 |
| Nanoparticles as Drug Carriers: Current Issues with in Vitro Testing MA Shetab Boushehri, A Lamprecht Nanomedicine 10 (21), 3213-3230, 2015 | 24 | 2015 |
| Alternative excipients for protein stabilization in protein therapeutics: overcoming the limitations of polysorbates AJ Castañeda Ruiz, MA Shetab Boushehri, T Phan, S Carle, P Garidel, ... Pharmaceutics 14 (12), 2575, 2022 | 22 | 2022 |
| Challenges of using lipopolysaccharides for cancer immunotherapy and potential delivery-based solutions thereto MA Shetab Boushehri, A Lamprecht Therapeutic delivery 10 (3), 165-187, 2019 | 12 | 2019 |
| Liposomal delivery of functional transmembrane ion channels into the cell membranes of target cells; a potential approach for the treatment of channelopathies S Ramadan, SN Tammam, MAS Boushehri, HG Breitinger, U Breitinger, ... International journal of biological macromolecules 153, 1080-1089, 2020 | 10 | 2020 |
| Cargo-free particles of ammonio methacrylate copolymers: From pharmaceutical inactive ingredients to effective anticancer immunotherapeutics MAS Boushehri, V Stein, A Lamprecht Biomaterials 166, 1-12, 2018 | 10 | 2018 |
| Preparation and characterization of a sustained release buccoadhesive system for delivery of terbutaline sulfate J Emami, MA ShetabBoushehri, J Varshosaz, A Eisaei Research in Pharmaceutical Sciences 8 (4), 219, 2013 | 10 | 2013 |
| Targeting Gαi/s proteins with peptidyl nucleotide exchange modulators B Nubbemeyer, AA Paul George, T Kühl, A Pepanian, MS Beck, ... ACS chemical biology 17 (2), 463-473, 2022 | 8 | 2022 |
| Adalimumab decorated nanoparticles enhance antibody stability and therapeutic outcome in epithelial colitis targeting M Ries, B Moulari, MA Shetab Boushehri, ME Ali, D Molnar, A Béduneau, ... Pharmaceutics 14 (2), 352, 2022 | 6 | 2022 |
| Polymeric matrix hydrophobicity governs saponin packing-density on nanoparticle surface and the subsequent biological interactions W Ahmad, MAS Boushehri, A Lamprecht Journal of Colloid and Interface Science 596, 500-513, 2021 | 4 | 2021 |
| Nanosphere-shaped ammonio methacrylate copolymers: converting a pharmaceutical inactive ingredient to efficient therapeutics for experimental colitis B Moulari, MAS Boushehri, JPP De Barros, T Faber, A Béduneau, ... Nanoscale 12 (17), 9590-9602, 2020 | 4 | 2020 |
| Sub-cytotoxic doses of pharmaceutical silica nanoparticles show significant impact on the proteome of HepG2 cells S Lorscheidt, MAS Boushehri, S Klaschik, A Lamprecht Journal of Controlled Release 306, 1-14, 2019 | 4 | 2019 |
| Modulation of nanostructure-based lipopolysaccharide active immunotherapy in cancer: size and composition determine short-and long-term tolerability MA Shetab Boushehri, T Yazeji, V Stein, A Lamprecht Molecular Pharmaceutics 16 (11), 4507-4518, 2019 | 3 | 2019 |
